Purpose: To evaluate the gut microbiome in individuals with Sjögrens and correlate bacterial profiles to dry eye (DE) measures.Methods: Prospective case series of individuals with confirmed (n=13) and unconfirmed (n=8) Sjögrens (n=21; cases) as compared to healthy controls (n=10). Stool was analyzed by 16S pyrosequencing and associations between bacterial classes and DE symptoms and signs were examined.
Results:Firmicutes was the dominant phylum in the gut, comprising 40-60% of all phyla. On a phyla level, subjects with Sjögrens (confirmed and unconfirmed) had depletion of Firmicutes (1.1-fold) and an expansion of Proteobacteria (3.0-fold), Actinobacteria (1.7-fold), and Bacteroidetes (1.3-fold) compared to controls. Shannon's diversity index showed no differences between groups with respect to the numbers of different OTUs encountered (diversity) and the instances these unique OTUs were sampled (evenness). On the other hand, Faith's phylogenetic diversity showed increased diversity in cases vs controls, which reached significance when comparing confirmed Sjögrens and controls (13.57 ± 0.89 and 10.96 ± 0.76, p=0.02). Using Principle Co-ordinate Analysis, qualitative differences in microbial composition were noted with differential clustering of cases and controls. Dimensionality reduction and clustering of complex microbial data further showed differences between the three groups, with regard to microbial composition, association and clustering. Finally, differences in certain classes of bacteria correlated with DE symptoms and signs.Conclusions: Individuals with Sjögrens have gut microbiome alterations as compared to healthy controls. Certain classes of bacteria were associated with DE measures.≤ 5 in either eye; or (3) an autoimmune disease (e.g. rheumatoid arthritis, psoriasis). The Miami VA and University of Miami Institutional Review Boards (IRB) approved the prospective evaluation of patients. Informed consent was obtained from all subjects and the study was adherent with the principles of the Declaration of Helsinki.Clinical metrics: Demographic information for each participant was collected including age, gender, race, ethnicity, past ocular and medical history and current medications.
DE symptoms:Participants completed two standardized DE symptoms questionnaires: the Dry Eye Questionnaire 5 (DEQ5) 18 (score 0-22) and the Ocular Surface Disease Index (OSDI) 19 (score 0-100).
DE signs:Participants underwent a complete ocular surface exam of both eyes in the following order: 1) Ocular surface inflammation via matrix metalloproteinase (MMP) 9 levels (Inflammadry, Quantel, San Diego, CA) 20 graded based on intensity of pink line (0 = no line, 1 = faint line, 2 = pink line, 3 = intense pink line). 2) Tear breakup time (TBUT) using fluorescein stain measured three times in each eye and averaged. 3) Corneal staining using fluorescein stain evaluated using the National Eye Institute (NEI) scoring scale which assesses 5 areas of the cornea on a 0-3 scale with a total score generated by summing the 5 section scores...